Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hormetic dose-response
- 6 January 2011
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 50 (3), 292-303
- https://doi.org/10.1111/j.1600-079x.2010.00839.x
Abstract
Melatonin (5–15 mg/kg) protects male animals against ischemic stroke. We explored the potential interactions and synergistic neuroprotection of melatonin and estrogen using a panel of lipid peroxidation and radical‐scavenging assays, primary neuronal cultures subjected to oxygen–glucose deprivation (OGD), and lipopolysaccharide (LPS)‐stimulated RAW 264.7 cells. Neuroprotective efficacy of melatonin was also evaluated in both reproductively active and ovariectomized female rats subjected to transient focal cerebral ischemia. Relative to melatonin or estradiol (E2) alone, a combination of the two agents exhibited robust, synergistic antioxidant and radical‐scavenging actions (P < 0.05, respectively). Additionally, the two agents, when combined at large doses, showed synergistic inhibition in the production of tumor necrosis factor alpha (TNF‐α) and interleukin‐6 (IL‐6) in the LPS‐stimulated RAW 264.7 cells (P < 0.05, respectively). Alternatively, co‐treatment with melatonin and E2 independently, but not combined, showed a U‐shaped dose‐responsive (hormetic) cytoprotection for neuronal cultures subjected to OGD. When combined at a dosage either positively or negatively skewed from each optimal dosage, however, co‐treatment caused synergistic neuroprotection. Relative to vehicle‐injected controls, melatonin given intravenously at 1–5 mg/kg, but not 0.1 or 15 mg/kg, significantly reduced brain infarction and improved neurobehavioral outcomes (P < 0.05, respectively) in reproductively active female rats. In ovariectomized stroke rats, melatonin was only effective at a large dosage (15–50 mg/kg). These results demonstrate complex interactions and synergistic antioxidant, radical‐scavenging, and anti‐inflammatory actions between estradiol and melatonin, and highlight the potential need to rectify the melatonin’s hormetic dose–response by the level of circulating estradiol in the treatment of female stroke patients.Keywords
This publication has 48 references indexed in Scilit:
- Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood–brain barrier permeability after transient focal cerebral ischemia in miceJournal of Pineal Research, 2006
- Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and agingMedical Hypotheses, 2005
- Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMKJournal of Pineal Research, 2005
- Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenationJournal of Biomedical Science, 2004
- Administration of Melatonin After Onset of Ischemia Reduces the Volume of Cerebral Infarction in a Rat Middle Cerebral Artery Occlusion Stroke ModelStroke, 2003
- Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System IschemiaStroke, 2000
- 17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female AnimalsStroke, 1999
- Gender-Linked Brain Injury in Experimental StrokeStroke, 1998
- Middle Cerebral Artery Occlusion in the Rat by Intraluminal SutureStroke, 1996
- Melatonin-binding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administrationEndocrinology, 1992